The importance of patient preferences for comorbidities in cost-effectiveness analyses
指出许多成本效果分析未考虑患者除主要疾病外的合并症，导致高估健康收益，建议纳入患者对合并症的偏好以统一比较成本效用比。
When using cost-effectiveness analyses to prioritize the allocation of health care resources across patients, a standard definition of effectiveness must be used. In an informal review of cost-effectiveness analyses, we found a heterogeneity in the methods used to qualify adjust years of life. Many studies do not account for the morbid conditions that patients experience other than the index condition being studied. These studies systematically overstate health benefit relative to studies that do for comorbidities. We recommend that patient preferences for comorbid conditions be incorporated into analyses to allow a consistent and facile comparison of cost-utility ratios for societal decision making.